Aardvark Therapeutics Inc (AARD)

12:20 PM

Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025 - The Manila Times

12:20 PM

12:00 PM

Aardvark (NASDAQ: AARD) to Start Phase 2 POWER Trial in 2025 for ARD-201 in obesity - Stock Titan

12:00 PM

07:09 AM

Real time social sentiment graph for Aardvark Therapeutics Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com

07:09 AM

04:04 AM

Why Aardvark Therapeutics Inc. stock is seen as undervaluedMarket Activity Summary & Free Daily Entry Point Trade Alerts - newser.com

04:04 AM

03:41 AM

Will Aardvark Therapeutics Inc. stock attract ESG investorsWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com

03:41 AM

03:18 AM

Is Aardvark Therapeutics Inc. forming a reversal patternJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com

03:18 AM

02:03 AM

Using AI based signals to follow Aardvark Therapeutics Inc.July 2025 Price Swings & High Conviction Trade Alerts - newser.com

02:03 AM

01:07 AM

Analyzing Aardvark Therapeutics Inc. with multi timeframe chartsJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com

01:07 AM

Nov 03, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Nov 03, 2025

Nov 03, 2025

Aardvark Therapeutics (Nasdaq: AARD) grants inducement options totaling 88,217 shares - Stock Titan

Nov 03, 2025

Nov 03, 2025

Aardvark Therapeutics (NASDAQ: AARD) sets Nov 11 & Nov 24 investor talks; live webcasts - Stock Titan

Nov 03, 2025

Nov 03, 2025

Is Aardvark Therapeutics Inc. stock undervalued vs historical averagesTrade Volume Report & Risk Controlled Daily Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Will Aardvark Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Action & Target Return Focused Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Is Aardvark Therapeutics Inc. stock attractive for income investorsJobs Report & Verified Momentum Stock Ideas - newser.com

Nov 03, 2025

Nov 02, 2025

Aardvark Therapeutics, Inc. (NASDAQ:AARD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025

Nov 02, 2025

Will Aardvark Therapeutics Inc. stock beat EPS estimates2025 Sector Review & Real-Time Buy Signal Notifications - newser.com

Nov 02, 2025

Oct 31, 2025

Is Aardvark Therapeutics Inc. forming a bottoming baseVolume Spike & Weekly Breakout Watchlists - newser.com

Oct 31, 2025

Oct 31, 2025

Is Aardvark Therapeutics Inc. building a consolidation baseGap Down & Free Long-Term Investment Growth Plans - newser.com

Oct 31, 2025

Oct 27, 2025

Aardvark Therapeutics Advances PWS Treatment with ARD-101 Study - TipRanks

Oct 27, 2025

Oct 27, 2025

Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome - TipRanks

Oct 27, 2025